ACTION: Addressing Cancer Treatment-related Insomnia Online in AtlaNtic Canada
The ACTION Study
The ACTION study was a randomized controlled trial for individuals who have been diagnosed with cancer and have issues with their sleep and memory, concentration, and attention. Participants completed 7 virtual sessions of
Cognitive Behavior Therapy for Insomnia (CBT-I). This treatment is designed to help address behaviors and thoughts that are known to influence the development and maintenance of sleep difficulties.
See what real study participants have to say about their experience in ACTION!
Study Findings
Click below to read more about the findings of this study:
1. Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors
2. Rationale and protocol for a randomized waitlist controlled trial of videoconference delivered cognitive behaviour therapy for insomnia (CBT-I) to improve perceived cognitive impairment (PCI) among cancer survivors
3. Impact and Mechanisms of Cognitive Behavioural Therapy for Insomnia on Fatigue among Cancer Survivors: A Secondary Analysis of a Randomized Controlled Trial
4. The effect of insomnia treatment on work productivity and related costs among cancer survivors with insomnia and comorbid perceived cognitive impairments: A secondary analysis of a randomized controlled trial
Published Abstracts
IPOS 2022 - 234 | Cost and Correlates of Productivity Loss Due to Insomnia Comorbid with Perceived Cognitive Impairment in Cancer Survivors
IPOS 2022 - 410 | Objective Cognitive Function in a Sample of Cancer Survivors with Insomnia and Cognitive Complaints
IPOS 2022 - 525 | Exploring Associations Between Insomnia, Mood Disturbance, and Subjective Cognitive Impairment Among Cancer Survivors
SLEEP 2023 - 0861 Does Cognitive Behavioral Therapy for Insomnia Reduce Productivity Loss in Cancer Survivors with Cognitive Impairment?
SLEEP 2023 - 0827 Effect of Virtual Cognitive Behavioral Therapy for Insomnia on Perceived Cognitive Functioning Among Cancer Survivors
CAPO 2023 - My Mind Just Feels Slowed Down’: Fatigue as a Contributor to Perceived Cognitive Impairment in Cancer Survivors
CAPO 2023 - Change in Objective Cognitive Function in Cancer Survivors with Insomnia and Perceived Cognitive Impairments Receiving Virtual Cognitive Behavioural Therapy for Insomnia
CAPO 2023 - Adverse Events in a Randomized Controlled Trial of Cognitive Behavioral Therapy for Insomnia in Patients with Perceived Cancer-Related Cognitive Impairments
CAPO 2024 - Exploring Expectancy and Perceptions of Credibility among Cancer Survivors with Cognitive Complaints who Received Treatment for Insomnia
CAPO 2024 - Improving cancer-related fatigue through cognitive behavioral therapy for insomnia: A secondary analysis of a randomized controlled trial
Investigators
Primary Investigator at Memorial University:
Sheila N. Garland, PhD
(Department of Psychology, Faculty of Science and Division of Oncology, Faculty of Medicine, MUN)
Co-Investigators:
Kara Laing, MD, FRCPC (Division of Oncology, Faculty of Medicine, MUN)
Joshua Rash, PhD, (Department of Psychology, Faculty of Science, MUN)
Melanie Seal, MD, FRCPC (Division of Oncology, Faculty of Medicine, MUN)
John Thoms, MD, FRCPC (Division of Oncology, Faculty of Medicine, MUN)
Josée Savard, PhD, (Département d'école de psychologie, Université Laval)
Veerabhadra Gadag, PhD, (Department of Biostatistics, Faculty of Medicine, MUN)
Robin Urquhart, PhD, (Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University)
Patient Co-Investigator:
Sondria Browne
Supported by a grant from the Canadian Institutes of Health Research (CIHR)
Copyright © 2018 Sleep, Health, & Wellness Lab - All Rights Reserved.
Do you want to join our mailing list?
Those on our mailing list will be the first to receive information about new studies, interesting findings from past studies, and more!